| AI | Artificial Intelligence |
| AS-OCT | Anterior Segment Optical Coherence Tomography |
| AMG | Amniotic Membrane Grafts |
| BP | Bullous Pemphigoid |
| CAS | Clinical Activity Score |
| DIF | Direct Immunofluorescence |
| EAACI | European Academy of Allergy and Clinical Immunology |
| EADV | European Academy of Dermatology and Venereology |
| ECM | Extracellular Matrix |
| EDV | European Dermatology Forum |
| EUGOGO | European Group on Graves’ Orbitopathy |
| FDA | Food and Drug Administration |
| GO-QOL | Graves’ Orbitopathy Quality of Life |
| IFN-γ | Interferon Gamma |
| IgG/IgA | Immunoglobulin G/A |
| IGF-1R | Insulin-Like Growth Factor-1 Receptor |
| IL | Interleukin |
| ILC | Innate Lymphoid Cells |
| IVCM | In Vivo Confocal Microscopy |
| JAK | Janus Kinase |
| LLLT | Low-Level Light Therapy |
| MAPK | Mitogen-Activated Protein Kinase |
| MMP-9 | Matrix Metalloproteinase-9 |
| OCP | Ocular Cicatricial Pemphigoid |
| OCT | Optical Coherence Tomography |
| OSDI | Ocular Surface Disease Index |
| PDE-4 | Phosphodiesterase-4 |
| ROS | Reactive Oxygen Species |
| SLE | Systemic Lupus Erythematosus |
| TAO | Thyroid-Associated Orbitopathy |
| Th | T Helper Cell |
| TLR | Toll-Like Receptor |
| TNF-α | Tumor Necrosis Factor Alpha |
| TSHR | Thyroid-Stimulating Hormone Receptor |
| TSI | Thyroid-Stimulating Immunoglobulin |
| VEGF | Vascular Endothelial Growth Factor |
| VEXAS | Vacuoles, E1 enzyme, X-linked, Autoinflammatory, and Somatic mutation syndrome |